Member Info for checkricky

Just been speaking to a very good friend of mine who runs a consortium of investors in South Africa and he said they are all talking about Hemogenyx and said they seem to think Hemogenyx is a strong financial position now and are about to announce a major update next week on a "cancer treatment breakthrough".. so it looks like the word is getting out slowly on a global level and international investors / partnerships the next few weeks maybe very big indeed...

https://www.stocktitan.net/news/HOPHF/hemogenyx-pharmaceuticals-plc-announces-invitation-to-participate-at-u6in476erjpj.html

Here we are £10

Go hemo go

970 to buy

I think everyone's had more than a few chances now to buy under £10 (2.5p) before the shareprice next leg up. Not much stock about & mm going to start playing games however I will hold for the next big RNS in the coming days...

3rd and final attempt at £10 & then we are ready for next weeks busy week...

I Was thinking £24 minimum hopefully we can close above £10 and get that boxed off which would only be( 2.5p).

Going into an important week next week with big news on the horizon... FOMO time

A positive day still today was expecting a bigger jump. However it is still a positive day... And tomorrow is FOMO Friday... I wouldn't want to be out of this stock during the weekend....

Just been looking into the invite and reading through it. It looks very very interesting high level global personalities attending and senior US officials.... This is great timing with all that hemogenyx have achieved and are soon big news expected to be announced in coming days... Will be the icing on the cake ... Love it

Well done hemogenyx and the team 👏

Hemogenyx rubbing shoulders with the international big boys now... this is the land of big money 💰

About DCNY Summit

The DCNY Summit (https://dcnysummit.org) is an annual high-level forum connecting Washington, DC and New York to bring together policymakers, corporate leaders, investors, and innovators. It is co-hosted by the Alliance Indus Foundation in partnership with Congressional leaders, the Embassy of India, Saudi Vision Invest, and other global organizations. The Summit serves as a platform for showcasing transformative companies, fostering international collaboration, and catalyzing financing and innovation across life sciences, healthcare, and technology sectors.

Hemogenyx Pharmaceuticals Invited to Participate at DCNY Summit

Hemogenyx Pharmaceuticals plc (LSE: HEMO), is pleased to announce that the Company has been invited to participate and present at the upcoming DCNY Summit, taking place in Washington, DC on 18 September 2025 and in New York on 22 September 2025.

The DCNY Summit is co-hosted by the Alliance Indus Foundation, together with Congressional leaders, the Embassy of India, Saudi Vision Invest, and other international partners, and is designed as a high-level forum connecting Washington, DC and New York to bring together policymakers, investors, corporate leaders, and innovators.

Hemogenyx will present its clinical progress and pipeline as part of the Summit's curated company showcase. Previous Summit participants have successfully secured significant growth capital, underscoring the Summit's reputation as a catalyst for financing and partnerships.

Participation in the DCNY Summit provides Hemogenyx with a valuable platform to:

· Highlight recent clinical milestones, including the ongoing Phase I clinical trial of its lead CAR-T cell therapy for acute myeloid leukemia (AML);

· Showcase the Company's broader therapeutic pipeline to an audience of influential stakeholders;

· Engage directly with investors, collaborators, and decision-makers at the intersection of science, healthcare, and finance.

Dr. Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented:

"We are honored to have been invited to present Hemogenyx at the DCNY Summit. This prestigious event convenes a remarkable group of global investors, corporate leaders, and policymakers, and provides us with a unique opportunity to highlight our progress and to engage with those who can help accelerate our mission to transform the treatment of cancer."

Wow I was lucky to have sold up this morning and put down for transferring fund to Hemo

WELL WHO'S RIGHT NOW

Next RNS due very soon will be the one to get this show off to the races 🏁

Anyone who is buying at these low levels here should be greatly rewarded but do your research... the shareprice should be much higher. But everyone has their own way of investing, and obviously those who have done their research will sit on hands knowing patience will pay off big time...

Blood rushing for many to buy in before the next leg up

As we are about to soon get a major RNS update on progress this will be a massive achievement moment for Hemogenyx. And for any new investors looking to jump on board this amazing opportunity all I say is look at the facts and let the facts do the talking look at the history over the last 18 months look at the RNS'S over the last 18 months there is no way the shareprice should not be this low now 750 odd (1.8p old money) is nothing absolute peanuts the shareprice should be a lot lot higher.

Look at all the positives regarding Hemogenyx Pharmaceuticals over the last 18 months All ready done the following:

. Manufacturing partnership with Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), to advance HG-CT-1

. New breed of strong cash rich investors with deep pockets & power backing HEMO 💪

. Next will advance to the 2nd adult dose cohort at twice the initial dose

· Initiate recruitment for the pediatric arm of the trial, addressing a critical unmet need in childhood AML.

.1st 2 patients treated with HG-CT-1 remain alive at 6 & 3 months post-treatment, respectively.

. 3rd & final patient has been successfully treated completing the 1st adult dose cohort

. Extra Clean room now ready for "Cash generative" 3 pronged pipeline approach

. Hemogenyx Awarded Grant (+ more 2 come)

. Streamlined cutting overhead cost approach means less funds needed going forward.

. Clearance to Proceed with Pediatric Expansion

. 2nd Patient Treated with HG-CT-1 CAR-T Therapy

. 1st Patient Treated with HG-CT-1 CAR-T Therapy

. 1st-in-Human Treatment with HG-CT-1 Clearance

. Opening of First Clinical Site

. IRB Approval for Phase I Clinical Trial

. CBR Brain Delivery

. CBR Intranasal Delivery

. FDA granted approval ( this is a massive achievement)

All of the above achieved in the last 18 months come on that some amazing work ok funding was needed along the way, however the business model has now changed grant's coming in as a few Patients treated and doing OK, cutting back on unnecessary salaries and Clean room will become cash generative. So yes it's all beginning to come together nicely now as hemogenyx beginning to rubs shoulders with the big boys.

Don't get distracted guys stay focused I didn't even look at this chat bb yesterday as I knew it was going to be high jacked by the nummpttys poster's try everything to distract investors. How can you spend all day banging on about how great you are and how everyone else is wrong mentally not right in the head...

To be egotistic is to be self-centered, conceited, and self-important, characterized by an inflated opinion of one's own features and significance. The term stems from the Latin word "ego," meaning "I," and describes a person who thinks they are more important than others and often behaves selfishly. The variant form egotistical is also commonly used.

.Key Characteristics of an Egotistic Person

Self-Absorption:

An egotistic person focuses excessively on themselves, often to the exclusion of others.

Inflated Self-Worth:

They tend to have an overly high opinion of their own abilities, importance, and qualities.

Vain and Conceited:

They are often proud, boastful, and believe they are superior to other people.

Selfishness:

Egotistic individuals may act in ways that are indifferent to the well-being or feelings of others.

A lot of buying going on today that's for sure

Go hemogenyx Go

If next RNS is good I expect a much higher price than 1500 honestly I'm looking 2400 + .... We need to crack 2400 and then we can comfortably say we are off to the races... We were comfortably over 1000 yesterday so hopefully we can have another attempt and go higher than 1050 during the day and hold above 1000... We are days away from another big RNS which will indicate a major milestone achievement for Hemogenyx...... Day by day the shareprice is only going higher from here imo

The answer to our resident doomsdayers Aldeballs quesyion is honestly no one give a fux about your questions can't you see that... Why you may ask ? putting on a concerning sensitive shoe on one foot and a back stabing one on the other.... We don't forget you absolutely spent all day trashing this bb a few months back and "we don't forget " your evil agenda won't cut it with any of us any more...

"A leopard doesn't change its spots" look it up Google it it is an idiom meaning that a person's fundamental character or nature is unlikely to change, especially if they have a bad habit or personality trait. The phrase, which originates from the Old Testament, is used to express skepticism about someone's ability to alter their ingrained personality or behavior. You will never change and your upto your old tricks again and we can see what your agenda is...

You used go on about funding well I'm sure you know hemogenyx has plenty of money now and has plenty of support going forward... Now your looking something else but we're not going to entertain you this time or anyone else for that matter...

And I will end with

GO HEMO GO .... This your time to shine